Artigo
Acesso aberto
Revisado por pares
A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection
2016; Massachusetts Medical Society; Volume: 375; Issue: 15 Linguagem: Inglês
10.1056/nejmoa1604330
ISSN1533-4406
Tópico(s)Hepatitis B Virus Studies
ResumoData from studies in nonhuman primates suggest that the triple monoclonal antibody cocktail ZMapp is a promising immune-based treatment for Ebola virus disease (EVD).
Referência(s)